Stella Mokiou, PhD, is a Global Oncology Real World Evidence (RWE) Scientist and Team Lead at Pfizer, focusing on developing strategic evidence generation and health outcomes plans in the oncology sector. With expertise in observational study design and health economics, Stella has held key roles at Merck Group, AstraZeneca, and Otsuka Pharmaceutical Companies Europe, where they shaped market access and health technology assessment strategies. Stella earned a PhD in Microbiology/Biotechnology from Cranfield University and has also contributed to regulatory affairs and clinical operations throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices